Gadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1- and T2-weighted MRI/CT/phosphorescence multimodality imaging

Biomaterials

Volumn 35, Issue 1, 2014, Pages 368-377

  Zhou, Jing ^a   Lu, Zhigao ^a   Shan, Guogang ^b   Wang, Sihui ^a   Liao, Yi ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

^b NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

CT; MRI; NaDyF4; Nanorods; Phosphorescence imaging; T1 and T2 weighted

Indexed keywords

FUNCTIONALIZED NANOPARTICLES; GADOLINIUM COMPLEXES; HYDROTHERMAL METHODS; MULTI-MODAL IMAGING; MULTI-MODALITY IMAGING; NADYF4; T1 AND T2-WEIGHTED; X-RAY COMPUTED TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY; GADOLINIUM; IRIDIUM; IRIDIUM COMPOUNDS; LIGHT EMISSION; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NANORODS; PHOSPHORESCENCE; PROBES; SYNTHESIS (CHEMICAL); TOXICITY;

LOADING;

ALPHA CYCLODEXTRIN; GADOLINIUM; IRIDIUM COMPLEX; IRIDIUM(1,2 DIPHENYL 1H BENZO(D)IMIDAZOLE) 2 (1 PHENYL 1H BENZO(D)IMIDAZOL 2 YL)QUINOLONE; NANOROD; OLEIC ACID; PENTETIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL LABELING; COMPUTER ASSISTED TOMOGRAPHY; DRUG CYTOTOXICITY; DRUG SOLUBILITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMAGE ENHANCEMENT; IMAGING PHANTOM; IMAGING SOFTWARE; IN VIVO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHORESCENCE; PRIORITY JOURNAL; TUMOR XENOGRAFT; X RAY ABSORPTION SPECTROSCOPY;

CT; MRI; NADYF(4); NANORODS; PHOSPHORESCENCE IMAGING; T(1) AND T(2)-WEIGHTED;

ANIMALS; GADOLINIUM; HELA CELLS; HETEROGRAFTS; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MALE; MULTIMODAL IMAGING; NANOTUBES; TOMOGRAPHY, X-RAY COMPUTED; X-RAY DIFFRACTION;

EID: 84887022377     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.088     Document Type: Article

References (40)

1. Lee D.E., Koo H., Sun I.C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41(7):2656-2672.
2. Liu Y., Ai K., Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to invivo applications. Acc Chem Res 2012, 45(10):1817-1827.
3. Lusic H., Grinstaff M.W. X-ray-computed tomography contrast agents. Chem Rev 2013, 113(3):1641-1666.
4. Mahmoudi M., Hosseinkhani H., Hosseinkhani M., Boutry S., Simchi A., Journeay W.S., et al. Magnetic resonance imaging tracking of stem cells invivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 2011, 111(2):253-280.
5. 1-weighted MRI and simultaneous anti-cancer drug delivery. Biomaterials 2012, 33(7):2388-2398.
6. Yang H., Zhuang Y., Hu H., Du X., Zhang C., Shi X., et al. Silica-coated manganese oxide nanoparticles as a platform for targeted magnetic resonance and fluorescence imaging of cancer cells. Adv Funct Mater 2010, 20(11):1733-1741.
7. Cheng L., Yang K., Li Y.G., Chen J.H., Wang C., Shao M.W., et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem Int Ed 2011, 50(32):7385-7390.
8. Yang H., Zhang C., Shi X., Hu H., Du X., Fang Y., et al. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging. Biomaterials 2010, 31(13):3667-3673.
9. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality invivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31(12):3287-3295.
10. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32(4):1148-1156.
11. 4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging. Biomaterials 2012, 33(26):6201-6210.
12. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for invivo dual-modality imaging. Adv Funct Mater 2011, 21(23):4470-4477.
13. Xing H.Y., Bu W.B., Zhang S.J., Zheng X.P., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33(4):1079-1089.
14. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33(18):4618-4627.
15. 4:Yb, Tm for lymphatic imaging invivo by real-time upconversion luminescence imaging under ambient light and high-resolution X-ray CT. Theranostics 2013, 3(5):346-353.
16. Lee N., Choi S.H., Hyeon T. Nano-sized CT contrast agents. Adv Mater 2013, 25(19):2641-2660.
17. 2 contrast agents for ultrahigh field magnetic resonance imaging. JPhys Chem Lett 2012, 3(4):524-529.
18. Caravan P., Greenfield M.T., Bulte J.W.M. Molecular factors that determine curie spin relaxation in dysprosium complexes. Magn Reson Med 2001, 46(5):917-922.
19. Vander Elst L., Roch A., Gillis P., Laurent S., Botteman F., Bulte J.W.M., et al. Dy-DTPA derivatives as relaxation agents for very high field MRI: the beneficial effect of slow water exchange on the transverse relaxivities. Magn Reson Med 2002, 47(6):1121-1130.
20. 3 (Ln=Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent. ACS Appl Mater Interfaces 2011, 3(9):3325-3334.
21. Holmberg R.J., Aharen T., Murugesu M. Paramagnetic nanocrystals: remarkable lanthanide-doped nanoparticles with varied shape, size, and composition. JPhys Chem Lett 2012, 3(24):3721-3733.
22. Mi P., Cabral H., Kokuryo D., Rafi M., Terada Y., Aoki I., et al. Gd-DTPA-loaded polymer-metal complex micelles with high relaxivity for MR cancer imaging. Biomaterials 2013, 34(2):492-500.
23. 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-ray computed tomography and magnetic resonance. Biomaterials 2012, 33(21):5394-5405.
24. Zhou J., Liu Z., Li F.Y. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2012, 41(3):1323-1349.
25. Liu Y., Tu D., Zhu H., Chen X. Lanthanide-doped luminescent nanoprobes: controlled synthesis, optical spectroscopy, and bioapplications. Chem Soc Rev 2013, 42(16):6924-6958.
26. Zhou J., Yao L.M., Li C.Y., Li F.Y. Aversatile fabrication of upconversion nanophosphors with functional-surface tunable ligands. JMater Chem 2010, 20(37):8078-8085.
27. Bian P., Zhou J., Liu Y., Ma Z. One-step fabrication of intense red fluorescent gold nanoclusters and their application in cancer cell imaging. Nanoscale 2013, 5:6161-6166.
28. Ding J., Gao J., Cheng Y., Xie Z., Wang L., Ma D., et al. Highly efficient green-emitting phosphorescent iridium dendrimers based on carbazole dendrons. Adv Funct Mater 2006, 16(4):575-581.
29. He L., Qiao J., Duan L., Dong G., Zhang D., Wang L., et al. Toward highly efficient solid-state white light-emitting electrochemical cells: blue-green to red emitting cationic iridium complexes with imidazole-type ancillary ligands. Adv Funct Mater 2009, 19(18):2950-2960.
30. 2+-selective chemodosimeter and logic gate. Inorg Chem 2011, 50(13):5969-5977.
31. Hu H., Xiong L.Q., Zhou J., Li F.Y., Cao T.Y., Huang C.H. Multimodal-luminescence core-shell nanocomposites for targeted imaging of tumor cells. Chem Eur J 2009, 15(14):3577-3584.
32. Liu Q., Chen M., Sun Y., Chen G.Y., Yang T.S., Gao Y., et al. Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence/fluorescence/positron emission tomography imaging. Biomaterials 2011, 32(32):8243-8253.
33. Zhao Q., Li F.Y., Huang C.H. Phosphorescent chemosensors based on heavy-metal complexes. Chem Soc Rev 2010, 39(8):3007-3030.
34. Zhao Q., Huang C.H., Li F.Y. Phosphorescent heavy-metal complexes for bioimaging. Chem Soc Rev 2011, 40(5):2508-2524.
35. Beija M., Afonso C.A.M., Martinho J.M.G. Synthesis and applications of rhodamine derivatives as fluorescent probes. Chem Soc Rev 2009, 38(8):2410-2433.
36. Zhao Q., Liu S., Shi M., Wang C., Yu M., Li L., et al. Series of new cationic iridium(III) complexes with tunable emission wavelength and excited state properties: Structures, theoretical calculations, and photophysical and electrochemical properties. Inorg Chem 2006, 45(16):6152-6160.
37. Sasaki M., Shibata E., Kanbara Y., Ehara S. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 tesla: A phantom study. Magn Reson Med Sci 2005, 4(3):145-149.
38. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99(9):2293-2352.
39. Xiong L.Q., Yang T.S., Yang Y., Xu C.J., Li F.Y. Long-term invivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31(27):7078-7085.
40. Cheng L., Yang K., Shao M.W., Lu X.H., Liu Z. Invivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine 2011, 6(8):1327-1340.